￥ 人民币 $ USD € 欧元
简体中文 English 繁体中文
Menu

News

Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
New targeted drug D-0316 has clinically significant efficacy in treating T790M+ and EGFR+ non-small cell lung cancer

2025-10-19 11:44:20

Check Details
New dosing regimen of pozitinib has better efficacy and tolerability in the treatment of non-small cell lung cancer_ Kanghule

2025-10-19 11:44:20

Check Details
New hope for c-Met+ non-small cell lung cancer, Telisotuzumab Vedotin is coming!

2025-10-19 11:44:20

Check Details
What patients with lung cancer need to know about using afatinib_Cortex

2025-10-19 11:44:20

Check Details
Afatinib has significant effect in the treatment of advanced lung squamous cell carcinoma_ Kanghule

2025-10-19 11:44:20

Check Details
The occurrence and treatment options of lung squamous cell carcinoma

2025-10-19 11:44:20

Check Details
The therapeutic effect of taking the targeted drug crizotinib in late-stage lung cancer

2025-10-19 11:44:20

Check Details
How effective is afatinib in the treatment of advanced lung squamous cell carcinoma?

2025-10-19 11:44:20

Check Details
What to do after afatinib is resistant to lung squamous cell carcinoma?

2025-10-19 11:44:20

Check Details
Contraindications and medication precautions for patients taking crizotinib

2025-10-19 11:44:20

Check Details
Crizotinib has significant efficacy in treating ALK-positive non-small cell lung cancer

2025-10-19 11:44:20

Check Details
The effect of afatinib treatment on patients with lung squamous cell carcinoma

2025-10-19 11:44:20

Check Details
Category
相关知识